
Thomas Polascik
Professor of Surgery
Duke University Medical Center
Thomas J. Polascik, M.D. is Professor in the Duke Cancer Institute, the Department of Surgery at the Duke University Medical Center, Durham, NC. Dr. Polascik trained at the Brady Urological Institute, the Johns Hopkins Hospital in Baltimore Maryland. After finishing his residency under the tutelage of Patrick C. Walsh M.D. he did an oncology fellowship under the mentorship of Alan W. Partin M.D. PhD. He then joined the faculty at Duke University and has been there since 1998. His clinical practice and research interests incorporate both prostate and kidney cancer.
In 2006 he developed an interest in the nascent field of focal therapy for prostate cancer. He is the founder and director, the International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer that began at Duke in 2008. The symposium has brought together investigators and clinicians from all regions of the world and the meeting alternates between North America and Europe with Co-chairs Drs Jean de la Rosette and Indy Gill. This past year marked the tenth annual meeting held in the Netherlands in February 2018.
Dr. Polascik is the Editor of Imaging and Focal Therapy of Early Prostate Cancer. He is the director of the Society of Urologic Oncology program at Duke and also the Genitourinary Program on Focal Therapy at the Duke Cancer Institute. His research interests include the development of image-guided therapies for early prostate cancer, the development of prostate cancer imaging techniques and minimally invasive treatment options for both prostate and kidney cancer. He has published over 300 manuscripts and book chapters. He has held positions on several boards of directors, advisory boards, and has been active in the North Carolina Urological Association and the Board of Directors with the Southeastern Section of the American Urological Association.
Presentation(s):
-
Prostate Cancer in 20 Years - Focal/Radiation
Friday, September 21
11:35 AM – 12:00 PM -
Focal Therapy for Urological Malignancy
Friday, September 21
5:15 PM – 6:15 PM